Skip to content

A Randomized, Fully-blinded Parallel Groups Study of Catheter Materials Used for Clean Intermittent Catheterisation

A Multi-centre, Double-blind, Randomized, Parallel Groups Study Comparing PVC and Polyolefin-based Elastomer (POBE) as Catheter Materials, Outcomes Will be Measured by Subject Perception.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00753298
Enrollment
195
Registered
2008-09-16
Start date
2007-01-31
Completion date
2008-03-31
Last updated
2021-11-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Urinary Catheterization

Brief summary

The study is designed as a randomized, double-blind, parallel-group, multi centre study comparing perception and tolerability of investigational product and comparator. In the randomized part of the study the subjects will be given either LoFric Primo (POBE) or the comparator LoFric Primo (PVC) for use over 4 weeks. The hypothesis is that subject perception and satisfaction of POBE is equal to or better than for PVC.

Interventions

DEVICELoFric Primo (POBE) single-use urinary catheter

LoFric Primo (POBE) single-use urinary catheter

DEVICELoFric Primo (PVC) single-use urinary catheter

LoFric Primo (PVC) single-use urinary catheter

Sponsors

Wellspect HealthCare
Lead SponsorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Provision of informed consent * Males and females aged 18 years and over * Experienced users of LoFric Primo with a minimum of one month of use * Practice CIC with LoFric Primo at least 3 times per day * Adults able to read, write and understand information given to them regarding the study

Exclusion criteria

* Ongoing symptomatic UTI * Suspicions of possible poor compliance with CIC during the study period * Previous enrolment or randomisation of treatment in the present study * Pregnancy * Subjects not able to perform self-catheterisation

Design outcomes

Primary

MeasureTime frameDescription
Subject's Perception Regarding Handling of Test Catheter Before InsertionAt 4 weeksSubject's perception regarding handling of test catheter before insertion, measured by mean score on a scale from 1 (Easy) to 5 (Troublesome)
Subject's Perception Regarding Handling of Test Catheter at InsertionAt 4 weeksSubject's perception regarding handling of test catheter at insertion, measured by mean score on a scale from 1 (Easy) to 5 (Troublesome)
Subject's Perception Regarding Handling of Test Catheter at WithdrawalAt 4 weeksSubject's perception regarding handling of test catheter at withdrawal, measured by mean score on a scale from 1 (Easy) to 5 (Troublesome)
Subject's Perception Regarding Handling of Test Catheter After WithdrawalAt 4 weeksSubject's perception regarding handling of test catheter after withdrawal, measured by mean score on a scale from 1 (Easy) to 5 (Troublesome)
Subject's General Satisfaction With Test CatheterAt 4 weeksSubject's general satisfaction with test catheter, measured by mean score on a scale from 1 (Very satisfied) to 5 (Absolutely not satified)
Subject's Sensation When Using Test CatheterAt 4 weeksSubject's sensation when using test catheter, measured by mean score on a scale from 1 (Comfortable) to 6 (Severe pain)

Countries

Austria, Germany, Italy, Netherlands, Sweden, United Kingdom

Participant flow

Participants by arm

ArmCount
LoFric Primo (POBE)
LoFric Primo (POBE) single-use urinary catheter (Arm A)
97
LoFric Primo (PVC)
LoFric Primo (PVC) single-use urinary catheter (Arm B)
98
Total195

Baseline characteristics

CharacteristicTotalLoFric Primo (POBE)LoFric Primo (PVC)
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
47 Participants23 Participants24 Participants
Age, Categorical
Between 18 and 65 years
148 Participants74 Participants74 Participants
Age, Continuous52 years
STANDARD_DEVIATION 16.66
52.5 years
STANDARD_DEVIATION 16.16
51.1 years
STANDARD_DEVIATION 17.2
Region of Enrollment
Austria
34 participants16 participants18 participants
Region of Enrollment
Germany
42 participants22 participants20 participants
Region of Enrollment
Italy
44 participants21 participants23 participants
Region of Enrollment
Netherlands
44 participants22 participants22 participants
Region of Enrollment
Sweden
28 participants14 participants14 participants
Region of Enrollment
United Kingdom
3 participants2 participants1 participants
Sex: Female, Male
Female
44 Participants25 Participants19 Participants
Sex: Female, Male
Male
151 Participants72 Participants79 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
3 / 977 / 98
serious
Total, serious adverse events
2 / 971 / 98

Outcome results

Primary

Subject's General Satisfaction With Test Catheter

Subject's general satisfaction with test catheter, measured by mean score on a scale from 1 (Very satisfied) to 5 (Absolutely not satified)

Time frame: At 4 weeks

ArmMeasureValue (MEAN)Dispersion
LoFric Primo (POBE)Subject's General Satisfaction With Test Catheter2.01 Score on scaleStandard Deviation 0.99
LoFric Primo (PVC)Subject's General Satisfaction With Test Catheter1.75 Score on scaleStandard Deviation 0.68
Primary

Subject's Perception Regarding Handling of Test Catheter After Withdrawal

Subject's perception regarding handling of test catheter after withdrawal, measured by mean score on a scale from 1 (Easy) to 5 (Troublesome)

Time frame: At 4 weeks

ArmMeasureValue (MEAN)Dispersion
LoFric Primo (POBE)Subject's Perception Regarding Handling of Test Catheter After Withdrawal1.63 Score on scaleStandard Deviation 1.05
LoFric Primo (PVC)Subject's Perception Regarding Handling of Test Catheter After Withdrawal1.69 Score on scaleStandard Deviation 0.98
Primary

Subject's Perception Regarding Handling of Test Catheter at Insertion

Subject's perception regarding handling of test catheter at insertion, measured by mean score on a scale from 1 (Easy) to 5 (Troublesome)

Time frame: At 4 weeks

ArmMeasureValue (MEAN)Dispersion
LoFric Primo (POBE)Subject's Perception Regarding Handling of Test Catheter at Insertion1.81 Score on scaleStandard Deviation 1.23
LoFric Primo (PVC)Subject's Perception Regarding Handling of Test Catheter at Insertion1.55 Score on scaleStandard Deviation 0.84
Primary

Subject's Perception Regarding Handling of Test Catheter at Withdrawal

Subject's perception regarding handling of test catheter at withdrawal, measured by mean score on a scale from 1 (Easy) to 5 (Troublesome)

Time frame: At 4 weeks

ArmMeasureValue (MEAN)Dispersion
LoFric Primo (POBE)Subject's Perception Regarding Handling of Test Catheter at Withdrawal1.55 Score on scaleStandard Deviation 0.93
LoFric Primo (PVC)Subject's Perception Regarding Handling of Test Catheter at Withdrawal1.44 Score on scaleStandard Deviation 0.77
Primary

Subject's Perception Regarding Handling of Test Catheter Before Insertion

Subject's perception regarding handling of test catheter before insertion, measured by mean score on a scale from 1 (Easy) to 5 (Troublesome)

Time frame: At 4 weeks

ArmMeasureValue (MEAN)Dispersion
LoFric Primo (POBE)Subject's Perception Regarding Handling of Test Catheter Before Insertion1.71 Score on scaleStandard Deviation 1.13
LoFric Primo (PVC)Subject's Perception Regarding Handling of Test Catheter Before Insertion1.76 Score on scaleStandard Deviation 1.05
Primary

Subject's Sensation When Using Test Catheter

Subject's sensation when using test catheter, measured by mean score on a scale from 1 (Comfortable) to 6 (Severe pain)

Time frame: At 4 weeks

ArmMeasureValue (MEAN)Dispersion
LoFric Primo (POBE)Subject's Sensation When Using Test Catheter1.86 Score on scaleStandard Deviation 0.9
LoFric Primo (PVC)Subject's Sensation When Using Test Catheter1.91 Score on scaleStandard Deviation 0.92

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026